Merck’s women’s health spinoff Organon looks for pharmaceuticals, diagnostics, devices to fill out its pipeline
Sandra Milligan, Organon’s head of R&D, sometimes wishes the women’s health spinoff was an oncology company. In cancer, the regulatory path is well-trodden. There are